References
- Kebabian J. W., Calne D. B. Multiple receptors for dopamine. Nature 1979; 277: 93–96
- Seeman P. Brain dopamine receptors. Pharmacol. Rev. 1981; 32: 229–313
- Creese I. Dopamine receptors explained. Trends Neurosci. 1982; 5: 40–43
- Lazareno S., Nahorski S. R. Selective labelling of dopamine (D2) receptors by 3H-domperidone but not by 3H-spiperone. Eur. J. Pharmacol., (in press).
- Nahorski S. R., Barnett D. B. Biochemical assessment of adrenoceptor function and regulation: new directions and clinical relevance. Clin. Sci., (in press).
- Stoof J. C., Kebabian J. W. Opposing roles for D1 and D2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 1981; 294: 366–368
- Baudry M., Martres M. P., Schwartz J. C. 3H-Domperidone: a selective ligand for dopamine receptors. Naunyn-Schmiedebergs Arch. Pharmacol. 1979; 308: 231–237
- Dickinson K. E.J., Nahorski S. R. Agonist binding to mammalian beta1 and beta2 adrenoceptors: modulation by guanine nucleotides and magnesium (this volume)
- Hulme E. C., Berrie C. P., Birdsall N. J.M., Burgen A. S.V. Two populations of binding sites for muscarinic antagonists in the rat heart. Eur. J. Pharmacol. 1981; 73: 137–142
- De Lean A., Kilpatrick B. F., Caron M. G. Guanine nucleotides regulate both dopaminergic agonist and antagonist binding in porcine anterior pituitary. Endocrinol. 1982; 110: 1064–1066
- Sibley D. R., Creese I. Pseudo non-competitive agonist interactions with dopamine receptors. Eur. J. Pharmacol. 1980; 65: 131–133